At a glance
ClinicalIndex Comparison RecordN/ACompleted· 623 enrolled
Drug / intervention
Physician-pharmacist collaborative interventionbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Improving Adherence to Blood Pressure Guidelines
In Brief
A clinical study evaluating Physician-pharmacist collaborative intervention for Hypertension. Completed, enrolled 623 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the impact of physician/pharmacist collaborative teams on hypertension guideline adherence for patients with uncontrolled hypertension in six family medicine practice sites in Iowa.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesUnited States
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)
Timeline
N/ACompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2003
First PostedSep 2005
Primary CompletionApr 2008
Study CompletionJul 2009
TodayJul 2026
First PostedSep 20, 2005
Enrollment StartAug 1, 2003
Primary CompletionApr 1, 2008
Study CompletionJul 1, 2009
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 20.8 years ago
Interventions
Physician-pharmacist collaborative interventionbehavioral
Participants receive assessment and medication and lifestyle recommendations from a clinical pharmacist.